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ABSTRACT

Original Article

Background/Aims: South Asia is an enigma for gastric cancer (GC) because it is a low risk region with a high
prevalence of Helicobacter pylori (H. pylori) infections. We evaluated the trend of GC clinical presentation and risk
factors in patients with dyspeptic symptoms.
Materials and Methods: The medical records of patients, coded by the international classification of diseases
(ICD-10-CM, 2015, Diagnosis Code C16.9) for malignancies of stomach diagnosed by esophagogastroduodenoscopy (EGD) and histopathology, were studied.
Results: 394 GC cases with a mean age of 54±15 years, range of 18 to 88, were analyzed. 256 (65%) were male.
Distal non-cardiac and cardiac tumors were 302 (77%) and 92 (23%) cases, respectively. The WHO classification
of GC defined 222 (56%) cases as intestinal type adenocarcinoma, 68 (17%) cases as signet ring cell carcinoma
(SRC), 62 (16%) cases as diffuse type and 42 (11%) cases as B cell non-Hodgkin lymphoma. The co-morbid conditions associated with GC were H. pylori infection (positive in 246 (62%) cases), diabetes mellitus type 2 (in 90
(23%) cases), and cigarette smoking (in 94 (24%) cases). Of the male patients, 88 (34%) (p<0.001) were smokers.
Body mass index was abnormal in all age groups and in both sexes. Cardiac regions for GC were more common
in the 46- to 60-year old age range and in males. Diffuse GC was seen in all age groups but there were significantly more common in the 18- to 45-year old age range. Gastric non-Hodgkin’s lymphoma was seen at an early
age of 18-45 years in 14(12%) and a later of 61-88 years in 20 (15%).
Conclusion: Intestinal type GC is common at all ages but SRC and diffuse GC are more common in patients less
than 50 years old. SRC and diffuse GC were not specific to the elderly in our study population.
Keywords: Gastric carcinoma, male, age, H. pylori, noncardiac, intestinal type carcinoma, signet cell carcinoma

INTRODUCTION
Gastric carcinoma (GC) is one of the major causes of
mortality and morbidity worldwide (1) and it is also one
of the leading causes of death worldwide (2). GC prognosis remains poor as it is rarely detected early, and the
majority of cases show distant metastasis at the time of
diagnosis (3,4). Developing countries account for twothirds of the reported incidences of GC worldwide (5).
The incidence of GC in both men and women is concentrated primarily in Asia, and the highest incidence
has been reported in Asian countries e.g. Japan, China
and Korea (6,7).

Helicobacter pylori (H. pylori) is a major cause of gastroduodenal ulcer and risk factor for GC and lymphoma.
In developing countries located in Asia e.g., Pakistan
and India, H. pylori infection is frequent in the general
population and occurs at an early age. In our country, H.
pylori is acquired at an early age and H.pylori seropositivity in children (11-15 years old) is 53.5% (8). In contrast, in developed Asian countries like Japan and Singapore, the frequency of H. pylori infection is reported
to be somewhat lower (9,10). In the United States, the
prevalence of H. pylori has decreased to approximately
10% in the white middle and upper class populations
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younger than 50 years old (11). H. pylori is transmitted by the
feco-oral route. It is associated with areas of overcrowding,
poor sanitation, lower socioeconomic status, and poor water
supply because these are risk factors for H. pylori infection. As a
result, there is a higher frequency and lower age of acquisition
for H. pylori in less developed Asian countries (12,13). In Pakistan, there is a high prevalence of H. pylori, but the prevalence
of GC is low. This study determined the distribution of GC in our
patients with upper gastrointestinal symptoms and risk factors
associated with GC.

gating growth, type III for ulcerating growth, and type IV for
diffusely infiltrating growth (linitis plastica in SRC).

MATERIALS AND METHODS
In this cross-sectional study, the medical records of patients
aged 18 years and over who attended the hospital were reviewed. These patients presented with pain, nausea or vomiting, weight loss, hematemesis, melena, and had an esophagogastroduodenoscopy (EGD) between January 2000 and
January 2016. The “gastric carcinoma cases” were defined as patients who fulfill the 2015 ICD-10-CM Diagnosis Code C16.9 for
malignancies of the stomach. Three hundred and ninety-four
patients fulfilled these criteria. The demographic characteristics
that were taken into account included: mean age, sex, address
of permanent residence, body weight (kg), height (cm), symptoms, use of medications [analgesics, proton pump inhibitors
(PPIs), etc.], diagnosis, blood glucose levels, lipid profile, hemoglobin levels, hemoglobinA1c levels, liver function test, complete blood count, H. pylori serology, (14) carbon labeled-urea
breath test (14C-UBT) or stool antigen test (HpSA), and tumor
markers [protein CA 125 (cancer antigen 125) and carcinoma
embryonic antigen (CEA)] were recorded. Cigarette smoking,
alcohol intake, and occupational history were also noted.

Histopathology
At the time of endoscopy, at least 2 or more biopsies were obtained from gastric abnormalities with standard biopsy forceps
and tissues were submitted for histopathological examination.
Specimens were fixed overnight in 10% buffered formalin and
gross examination performed the next day was followed by
paraffin embedding. Slides were stained with hematoxylin and
eosin. The reporting (according to the TNM staging system) incorporated gross examination, tumor location, type and grade,
depth of invasion, surgical resection margins, and lymph node
status. Histological classification of GC was based on Lauren’s
criteria (15).

Study Design
This was a cross sectional study.
Setting
Retrospective data collection from patient medical records was
performed after obtaining approval by the institutional ethics
review committee.
Inclusion Criteria
All patients, irrespective of sex, age, and ethnic background,
that presented with upper gastrointestinal symptoms and
diagnosed as having GC between January 2000 and January
2016 were included.
Exclusion Criteria
Individuals with a history of gastrectomy for GC, aplastic anemia, scleroderma, gastric lymphoma, and gastrointestinal stromal tumor (GIST) were excluded.
Endoscopy
The morphology of GC was described as exophytic, ulcerated,
infiltrative, or combined. Bormann’s classification described the
appearance of GC as type I for polypoid growth, type II for fun-

Esophageal carcinoma anatomic classification was if its epicenter was in the lower thoracic esophagus or gastroesophageal
junction (GEJ) or within the proximal 5 cm of stomach (i.e., cardia) with the tumor mass extending into GEJ or distal esophagus. If the origin was >5 cm distal to the GEJ, or within 5 cm of
GEJ but did not extend into GEJ or esophagus, it was grouped
as GC (14).
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Statistical Analysis
Results were expressed as mean±standard deviation. Univariate analysis was performed using an independent sample
t-test, Pearson Chi-square test or Fisher Exact test where applicable. A p value <0.05 was considered significant. Statistical interpretation of data was performed using IBM Statistical
Package for the Social Sciences Statistics (IMB SPSS Statistics;
Armonk, NY, USA) version 19.0.
Technique
The technique used was non-probability consecutive sampling.
Data Collection Procedure
Exemption from the institutional ethics review committee
(ERC) was obtained. All pathologically documented gastric
cancer records during a 16-year period (from 2000 to 2016)
were recorded. Cases of GC presenting for the first time during
the 16- year period were identified. All demographic, clinical,
and endoscopic data from each patient were gathered and
analyzed.
RESULTS
There were 394 cases. The mean age was 53±15 (range: 18-88)
years of age. Male patients constituted 256 (65%) cases and
138 (35%) cases were female patients.
Risk Factors
There was no difference in the distribution of H. pylori infection in
patients in relation to age, sex, and site of malignancy (Table 1, 2).
The co-morbid conditions associated with GC were diabetes mellitus type 2 in 90 (23%) case, essential hypertension in
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Table 1. Clinical details of the patients with gastric carcinoma (n=394)
Age (year) mean±SD
Range
Sex
Male/Female

Original Article

Symptoms
Weight loss
Nausea
Loss of appetite
Epigastric pain
Dysphagia
Melena
Constipation
Gastric outlet obstruction
Hematemesis
Endoscopy features
Diffuse
Fungoid
Ulceration
Polypoid
Site of tumor
Cardiac
Non-cardiac
Histology
Intestinal type
Signet cell carcinoma
Diffuse
Lymphoma
Histology
Well differentiated
Moderately differentiated
Poorly differentiated
Risk factors
Helicobacter pylori
Cigarette smoker
Alcohol
Metastases
Lymph nodes
Peritoneum
Liver
Pulmonary
Bone
Small intestine
Pancreas

54±15
18-88
256/138
n (%)
290 (74)
232 (59)
216 (55)
184 (53)
114 (29)
66 (17)
68 (17)
54 (14)
48 (12)
224 (59)
76 (19)
66 (17)
18 (5)
92 (23)
302 (77)
222 (56)
68 (17)
62 (16)
42 (11)
74 (19)
194 (49)
126 (32)
246 (62)
94 (24)
12 (3)
228 (60)
64 (16)
48 (13)
38 (11)
8 (2)
4 (1)
4 (1)

68 (23%) cases, and cigarette smoking in 94 (24%) cases. The
distribution of GC was not related to the history of smoking.
However, male patients [88 (34%) cases (p<0.001)] were more
commonly smokers than female patients [6 (4%) cases] (Table
2). Body mass index was noted to be abnormal in all the age
groups and in both sexes (Table 2).
Gastric Tumors
Gastric carcinoma arising from the non-cardiac region of the
stomach was equally common in all age groups (Table 2).
However, cardiac region tumors were more common in 46- to
60-year old patients and in males (Table 2). GC arising in the
antrum were common in the 18 to 45-year old age group [68
(60%) cases (p=0.196)], but they were equally common in the
two other age groups (Table 2). GC arising from the gastric
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lesser curve were more common in male patients compared
to female patients and in the 46- to 60-year old age group
[38 (25%) cases (p=0.006)] compared to the other age groups
(Table 2). Diffuse GC was seen in all three age groups, but they
were significantly more common in the younger age group
(18- to 45-year old) and did not show any sex-related distribution (Table 2). Intestinal type GC was found equally in all age
groups and also did not show any sex-related distribution (Table 2). GC, fungoid in shape in 36 (28%) cases, was significantly
more common in the 61- to 88-year old age group than in the
younger age groups (Table 2). SRCs were found frequently in
the 18 to 45-year old and 46- to 60-year old age groups (Table
2). Gastric non-Hodgkin’s lymphoma was not associated with
sex and demonstrated two peaks in our patients: 14 (12%)
cases in the 18- to 45-year old group and 20 (15%) cases in the
61- to 88-year old group (Table 2).
Gastric Metastases
Lymph node metastases were equally common in all age
groups and marginally more common in female patients than
male 98 (71%) vs. 156 (61%) (p=0.046), respectively (Table 2).
Liver metastases were common in the older age group and occurred equally in both sexes (Table 2). Pulmonary metastases
were also significantly more common in the older age group
and in female patients [32 (23%) cases (p<0.001)] compared to
male patients (26 (10%) cases) (Table 2). Peritoneal metastases
were common in the 18- to 45-year old age group compared
to the older age groups, and also significantly more common
in females [32 (23%) cases (p<0.001)] compared to males [26
(10%) cases] (Table 2).
DISCUSSION
Gastric carcinomas were twice more common in males than
in females. Only 32% of the GC cases were seen in elderly patients (61- to 88-year old age group). The study did not show a
significant distribution in the elderly population as our patients
with GC had a median age of 55 years. This is different from GC
prevalence in other populations where GC is usually observed
in patients 70 and older (16). Among the risk factors for GC, the
H. pylori infection factor did not vary in the different age groups
nor demonstrated a sex distribution (Table 2). H. pylori infection
diagnoses involved in these cases was biopsy obtained at endoscopy for histology and did not include usage of a 14C-UBT
or HpSA test, which are better diagnostic tests (17). In practice,
the H. pylori treatment prescribed is not based on local H. pylori antibiotic sensitivities. Post-treatment of H. pylori infection,
there was an absence of documentation regarding eradication
of the infection.
Smoking was common in all age groups, particularly in male
patients (Table 2). This is in keeping with our National Health
Survey, which described 46% men and 5.7% women as smoking tobacco (contributing to 80,000 deaths annually) (18). A
cross sectional survey in a tertiary care center revealed that
39% of patients aged 18 years or older had either hypertension
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Table 2. Association of gastric carcinoma with age and sex
Age			 Sex

Group I
Group II
(18- to 45-year olds) (46- to 60-year olds)
n=114
n=152

Group II
(61- to 88- year olds)		
n=128
p

Male
n=256

Female
n=138

p

Site 							
Cardia							
Yes
18 (16)
48 (32)
26 (22)
0.007
70 (27)
22 (16)
0.011*
No
96 (84)
104 (68)
102 (78)		
186 (73)
116 (84)
Fundus							
Yes
20 (18)
36 (24)
40 (31)
0.045
68 (27)
28 (20)
.166
No
94 (82)
116 (76)
88 (69)		
188 (73)
110 (80)
Corpus							
Yes
38 (33)
52 (34)
46 (36)
0.909
80 (31)
56 (41)
0.063
No
76 (67)
100 (66)
82 (64)		
176 (69)
82 (59)
Antrum							
Yes
68 (60)
74 (49)
66 (52)
0.196
128 (50)
80 (58)
0.131
No
46 (40)
78 (51)
62 (48)		
128 (50)
58 (42)
Lesser curve							
Yes
14 (12)
38 (25)
16 (12)
0.006
56 (22)
12 (9)
0.001
No
100 (88)
114 (75)
112 (88)		
200 (78)
126 (91)
Greater curve							
Yes
8 (7)
14 (9)
16 (13)
0.344
28 (11)
10 (7)
0.236
No
106 (93)
138 (91)
112 (87)		
228 (89)
128 (93)
Boremann classification							
Polypoid
4 (3)
6 (4)
8 (6)
0.001
16 (6)
2 (1)
0.070
Fungoid
12 (10)
28 (18)
36 (28)		
46 (18)
30 (22)
Ulcerating
18 (16)
20 (13)
28 (22)		
46 (18)
20 (15)
Diffuse
110 (72)
98 (65)
56 (44)		
148 (58)
86 (62)
WHO GCa Classification 							
Adenocarcinoma							
Intestinal type
34 (30)
54 (37)
48 (38)		
96 (38)
40 (29)
Papillary
0 (0)
0 (0)
2 (2)		
2 (1)
0 (0)
Mucinous
0 (0)
6 (4)
4 (3)		
10 (4)
0 (0)
Signet ring cell
26 (23)
32 (21)
10 (8)		
38 (15)
30 (22)
Adenoosquamous
4 (3)
4 (2)
0 (0)
<0.001
4 (2)
4 (3)
0.022
Diffuse
36 (32)
42 (27)
34 (26)		
70 (27)
42 (30)
GI stromal tumor
0 (0)
2 (1)
4 (3)		
4 (2)
2 (1)
Lymphoma
14 (12)
8 (5)
20 (15)		
24 (9)
18 (13)
Metastatic carcinoma
0 (0)
4 (3)
6 (5)		
8 (3)
2 (1%)
Metastases							
Lymph nodes 							
Yes
84 (74)
98 (64)
72 (56)
0.018
156 (61)
98 (71)
0.046
No
30 (26)
54 (36)
56 (44)		
100 (39)
40 (29)
Liver							
Yes
4 (4)
20 (13)
18 (14)
0.005
32 (12)
10 (7)
0.107
No
110 (96)
132 (87)
110 (86)		
224 (88)
128 (93)
Pulmonary							
Yes
4 (4)
20 (13)
20 (16)
0.003
26 (10)
32 (23)
<0.001
No
110 (96)
132 (87)
108 (84)		
230 (90)
106 (77)
Peritoneal							
Yes
24 (21)
20 (13)
14 (11)
0.067
26 (10)
32 (23)
<0.001
No
90 (79)
132 (87)
114 (89)		
230 (90)
106 (77)
Risk factors 							
Cigarette smoker							
Yes
24 (21)
36 (24)
34 (27)
0.603
88 (34)
6 (4)
<0.001
No
90 (79)
116 (76)
94 (73)		
168 (66)
132 (96)
Body mass index (BMI)							
Healthy<23
8 (7)
2 (1)
4 (3)
0.047
2 (1)
12 (8)
<0.001
Over weight>23
106 (93)
150 (99)
124 (97)		
254 (99)
126 (91)
Helicobacter pylori							
Positive
68 (60)
92 (60)
86 (67)
0.397
160 (63)
86 (62)
0.972
Negative
46 (40)
60 (40)
42 (33)		
96 (37)
52 (38)
Diabetes mellitus							
Positive
18 (16)
30 (20)
42 (33)
0.004
56 (22)
34 (25)
0.533
Negative
96 (84)
122 (80)
86 (67)		
200 (78)
104 (75)
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or dyslipidemias with a history of active smoking (19). Based on
the data of the National Health Survey, the overall prevalence
of smoking among 15-year olds or older was 15.2% and the
prevalence of smoking was 28.6% in men compared to 3.4% in
women (20). The incidence of GC in male patients was in keeping with the prevalence of smoking in the male population. Increased salt intake has been described as an independent risk
factor of GC. In a population based study, an increased dietary
salt intake was documented among different communities in
Karachi (21). Furthermore, according to the National Health
Survey, 25.0% of the population was overweight or obese (22).
The majority of patients with GC had a BMI that was deemed
“overweight” in the majority of our GC patients, regardless of
age or sex (Table 2). This is in agreement with the high BMI that
was associated with the distribution of GC. Diabetes mellitus
type 2 was significantly associated with GC in all age groups
with a marked distribution in the 61- to 88-year old group [33%
(p=0.004)] (Table 2). This is in keeping with the high prevalence
of diabetes mellitus in this age group (equal sex distribution).
According to the 2011 figure of the World Health Organization,
the prevalence of diabetes mellitus in our population was the
7th highest in the world at 12.9%, which is the 10% of our population (23).
The gastric rich lymphatic and vascular supply explained extensive lymph node and liver metastases in GC at presentation. Lymph nodes metastases were equally common in all
age groups regardless of sex. However, they were more common in the early age group of 18- to 45-year olds (84 (74%)
cases) compared the older age group of 61- to 88-year olds (72
(56%) cases) (Table 2). At presentation, liver metastases were
common in the two older age groups (Table 2). Pulmonary
metastases [32 (23%) cases (p<0.001)] were more common in
female compared to male (26 (10%) cases) patients. In previous studies, diffuse GC was found commonly in young female
patients (24,25) while intestinal GC (associated with intestinal
metaplasia) and H. pylori infection was found equally in all age
groups (25,26). In an earlier local study, 53% of GC cases were
located in the gastric antrum and 35% in the proximal part (27).
However in the present study, distal gastric tumors and cardiac
tumors were 77% and 23%, respectively (Table 1).
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